WideCells Group PLC (LSE:WDC) - Share price - Overview

Stock Report

WideCells Group PLC WDC

Last Price
GBX11.63

Day Change
0.00|0.00%

As of 26/05/2017
12:35:29 BST | GBX
Minimum 15 Minutes Delay.

Last Close11.63p
Day Range11.82 - 11.82
Mkt Cap6.91Mil
52-Wk Range11.00 - 16.30
Yield %0.00
ISINGB00BD060S65
Volume12,665
P/E-3.88
P/S184.52
P/CF-6.09

Share Price

Total Returns 26/05/2017

 Chg (%)  
More ...
WideCells Group PLC-7.92 
FTSE 100 TR GBP4.15
 
Financials
201420152016
More ...
Income Statement
Turnover0.120.050.03
Operating Profit-0.25-0.28-1.24
Net Profit-0.27-0.29-1.28
Reported EPS-0.35-0.44-3.00
Balance Sheet
Current Assets0.060.101.24
Non Current Assets0.050.030.39
Total Assets0.110.131.63
Current Liabilities0.340.820.56
Total Liabilities0.340.820.81
Total Equity-0.22-0.690.82
Cash Flow
Operating Cash Flow-0.17-0.21-0.74
Net Change in Cash0.010.031.12
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
28/04/2017PurchaseDr Graham Hine12.0040,0004,800.00
28/04/2017PurchaseJoao Andrade12.0020,0002,400.00
28/04/2017PurchaseJoao Gil12.0015,0001,800.00
28/04/2017PurchaseDavid Bridgland12.0080,0009,600.00

Company Profile

WideCells Group PLC is a provider of stem cell services. Its business is separated into three divisions each of which is operated under a separate brand including CellPlan, WideCells and WideAcademy.

Sector

Medical Care

Market Position

1593 of 1851 Companies

Index

Outlook

(02/05/2017) ceo - "I believe that our business is well placed for a value re-rate in 2017 as we bring our various work-streams over the line"

Next Event 22/06/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)0.0020.6216.87
Div Yld (E)0.001.594.05
PEG (E)0.000.730.72
ROCE-100.0019.1715.97
Op Mrgn-4,948.00-3.391.61
EPS Grwth0.0028.6627.17
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr Graham Hine
Group Chief Executive OfficerJoao Andrade
Group Chief Financial Officer & CompanyDavid Bridgland
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.